Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Total 13F shares
-
13,788,837
-
Share change
-
+12,378,148
-
Total reported value
-
$218,726,000
-
Price per share
-
$15.95
-
Number of holders
-
18
-
Value change
-
+$196,226,000
-
Number of buys
-
17
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q4 2015
As of 31 Dec 2015 Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,788,837 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, LLC, FMR LLC, Foresite Capital Management III, LLC, Redmile Group, LLC, New Leaf Venture Partners, L.L.C., Clough Capital Partners L P, Cormorant Asset Management, LLC, JENNISON ASSOCIATES LLC, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC.
This table shows 18 institutional shareholders of the security as of 31 Dec 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.